文献速递呼吸道感染呼吸危重症与机械通气

吸烟通过增强中性粒细胞CSF3表达损害流感感染时的肺泡毛细血管屏障功能

Cigarette smoke augments CSF3 expression in neutrophils to compromise alveolar-capillary barrier function during influenza infection.
PubMed 文献 · Eur Respir J · 2022-08-25

本研究利用小鼠模型探究吸烟加重流感感染的免疫机制。吸烟暴露加重病毒性肺炎水肿、低氧血症和肺中性粒细胞增多,间质性而非气腔中性粒细胞增多预示发病率。吸烟与流感共同导致CSF3和IL-6表达加剧,补充rCSF3加重病情,而抗CSF3R治疗改善肺泡毛细血管屏障功能。

要点

  • 吸烟加重流感病毒性肺炎的水肿、低氧和肺中性粒细胞增多
  • 间质性中性粒细胞增多而非气腔中性粒细胞增多预示发病率
  • 抗CSF3R治疗可改善吸烟暴露感染小鼠的肺泡毛细血管屏障功能

核心结论

  • 吸烟通过加剧CSF3表达和CSF3R信号损害流感感染时的肺泡毛细血管屏障功能,抗CSF3R治疗可能成为潜在治疗靶点,而临床rCSF3治疗在病毒感染性疾病中可能存在局限。

研究设计与样本

  • 采用小鼠模型同时暴露于香烟烟雾和H1N1流感病毒感染,并使用CSF3补充/CSF3R阻断及单细胞RNA测序进行研究。

主要发现

  • 吸烟暴露加重病毒性肺炎特征如水肿、低氧血症和肺中性粒细胞增多。
  • 吸烟暴露感染小鼠病毒RNA增加,但未增加有复制能力的病毒颗粒。
  • 间质性而非气腔中性粒细胞增多正向预测吸烟暴露感染小鼠的发病率。
  • 吸烟暴露和流感背景下CSF3和白细胞介素-6表达加剧。
  • 补充重组CSF3加重流感病情、低体温和水肿,而抗CSF3R治疗改善肺泡毛细血管屏障功能。

临床怎么用

  • 吸烟的流感患者可能从抗CSF3R治疗中获益,但需进一步临床验证。
  • 临床使用重组CSF3治疗病毒性疾病时需谨慎考虑其潜在加重病情的风险。

局限性

  • 研究基于小鼠模型,结果外推到人类需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cigarette smokers are at increased risk of acquiring influenza, developing severe disease and requiring hospitalisation/intensive care unit admission following infection. However, immune mechanisms underlying this predisposition are incompletely understood, and therapeutic strategies for influenza are limited. METHODS: We used a mouse model of concurrent cigarette smoke exposure and H1N1 influenza infection, colony-stimulating factor (CSF)3 supplementation/receptor (CSF3R) blockade and single-cell RNA sequencing (scRNAseq) to investigate this relationship. RESULTS: Cigarette smoke exposure exacerbated features of viral pneumonia such as oedema, hypoxaemia and pulmonary neutrophilia. Smoke-exposed infected mice demonstrated an increase in viral (v)RNA, but not replication-competent viral particles, relative to infection-only controls. Interstitial rather than airspace neutrophilia positively predicted morbidity in smoke-exposed infected mice. Screening of pulmonary cytokines using a novel dysregulation score identified an exacerbated expression of CSF3 and interleukin-6 in the context of smoke exposure and influenza. Recombinant (r)CSF3 supplementation during influenza aggravated morbidity, hypothermia and oedema, while anti-CSF3R treatment of smoke-exposed infected mice improved alveolar-capillary barrier function. scRNAseq delineated a shift in the distribution of Csf3 + cells towards neutrophils in the context of cigarette smoke and influenza. However, although smoke-exposed lungs were enriched for infected, highly activated neutrophils, gene signatures of these cells largely reflected an exacerbated form of typical influenza with select unique regulatory features. CONCLUSION: This work provides novel insight into the mechanisms by which cigarette smoke exacerbates influenza infection, unveiling potential therapeutic targets (e.g. excess vRNA accumulation, oedematous CSF3R signalling) for use in this context, and potential limitations for clinical rCSF3 therapy during viral infectious disease.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. McGrath JJC, Vanderstocken G, Dvorkin-Gheva A, et al. Cigarette smoke augments CSF3 expression in neutrophils to compromise alveolar-capillary barrier function during influenza infection. Eur Respir J. 2022. PMID: 35058252. doi:10.1183/13993003.02049-2021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。